Last updated on September 2007

PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena


Brief description of study

The acid secretion in the stomach seems to increase after withdrawal of min. 8 wks of treatment with a PPI (protonpump inhibitor) It is unknown if this acid rebound phenomenon is of clinical significance. In a doubleblinded and placebocontrolled study healthy volunteers are randomized to treatment with placebo or PPI + placebo. Gastrointestinal symptoms are scored once a week and.

Clinical Study Identifier: NCT00526006

Find a site near you

Start Over